Orthogon Therapeutics

Orthogon Therapeutics develops novel antiviral medicines, focusing on first-in-class treatments for BK virus reactivation in transplant patients. They utilize small molecule drugs targeting viral proteins, addressing an unmet medical need in managing BK virus infections and improving transplant outcomes.

Buy Funded Startups lists

Funding Round:

Funding Amount: $5.2M

Date: 10-Dec-2024

Investors:

Markets: Biotechnology, Pharmaceuticals, Antiviral

HQ: Canton, Massachusetts, United States

Founded: 2012

Website: https://www.orthogontherapeutics.com

LinkedIn: https://www.linkedin.com/company/orthogon-therapeutics

Twitter: https://twitter.com/PledgeTx

Instagram: